
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.
Given the huge phenotypic and genetic heterogeneity of acute and continual myeloid malignancies, hematologists have eagerly awaited the introduction of .....